Zembron-Lacny, A., Szyszka, K., and Szygula, Z
GLP-1 class safety monitoring should include awareness of these important risks: Pancreatitis : Patients should promptly report severe abdominal pain, with or without vomiting Gallbladder disease : Report symptoms of biliary colic or cholecystitis Acute kidney injury : Maintain adequate hydration, especially if experiencing nausea/vomiting Hypoglycemia : Increased risk when used with insulin or sulfonylureas Suicidal ideation : For patients using Wegovy or Zepbound, monitor for mood changes Patients should be counseled to report any neck swelling, difficulty swallowing, persistent hoarseness, or palpable thyroid nodules, as these warrant evaluation regardless of GLP-1 use
Throughout the diet, they have a low-calorie consumption
[DOI] [PubMed] [Google Scholar] 45.Reich K, Leonardi C, Lebwohl M, et al
Consulting a healthcare provider can help determine the safest course of action based on an individual's health status and medical history [2]
Required for zinc and selenium absorption which are vital for thyroid health